Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.0575    0.00 (0.00%)
Bid:
0.055
Ask:
0.06
Spread: 0.005 (9.091%)
Market Cap: £3.29m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Conversion of Loan - REPLACEMENT

31 Aug 2011 11:42

RNS Number : 3274N
Empyrean Energy PLC
31 August 2011
 

The following amendments have been made to the 'Director/PDMR Shareholding' announcement released on 16 August 2011 at 9.43am under RNS No 4309M and to the 'Issue of Equity' announcement released on 24 August 2011 at 8.54am under RNS No 9358M.

 

31 August 2011

 

Empyrean Energy PLC

("Empyrean" or the "Company"; Ticker (EME))

 

 

The Company announces that, due to incorrect data being applied to the calculations, an incorrect weighted average price per ordinary share traded ("VWAP") in the Company's shares was used in relation to conversions, into new ordinary shares, of the funds drawn down under the convertible loan facility (the "Loan") which were announced on 16 August 2011 and 24 August 2011.

 

The VWAP for the conversion of £500,000 of the Loan plus interest beneficially owned by Apnea Holdings Pty Ltd (Apnea") was 4.81p, not 4.87p per ordinary share. Consequently, a further 136,652 new ordinary shares, representing 0.07% of the enlarged issued share capital, need to be issued to Apnea, a company controlled and associated with CEO, Tom Kelly. As a result, Tom Kelly now has an interest in 19,591,562 ordinary shares representing approximately 9.96% of the Company's shares in issue.

 

The VWAP for the conversion of the £151,000 of the Loan plus interest, announced on 24 August 2011, was 4.98p, not 5.00p per ordinary share. Consequently, a further 10,943 new ordinary shares, representing 0.02% of the enlarged issued share capital, need to be issued.

 

Application has been made for the 147,594 new Ordinary Shares to be admitted to AIM and dealings are expected to commence on 7 September 2011. The balance of the loan, amounting to £849,000 remains drawn down.

 

Following the issue of the shares, Empyrean's total issued and voting share capital will comprise of 196,754,015 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company.

 

 

Contact:

 

Empyrean Energy Plc

Tom Kelly Tel: +618 9388 8041

 

Shore Capital & Corporate Limited

Anita Ghanekar Tel: +44 (0) 20 7408 4090

Edward Mansfield

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAORRARAWOAR
Date   Source Headline
5th Feb 20252:47 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNS£675,000 Placing
28th Jan 20253:39 pmRNSHolding(s) in Company
28th Jan 20257:50 amRNSLand access agreement for Wilson River 1 secured
23rd Jan 20257:00 amRNSParticipation option in the Wilson River prospect
6th Jan 20257:00 amRNSHolding(s) in Company
18th Dec 20247:00 amRNSInterim Results
4th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:14 pmRNSResults of General Meeting
13th Nov 20247:00 amRNSPosting of Circular
12th Nov 20249:00 amRNSChange of Registered Office Address
11th Nov 202410:15 amRNSResults of Retail Offer
6th Nov 20247:22 amRNSRetail Offer
6th Nov 20247:00 amRNSProposed Fundraise and Capital Reorganisation
28th Oct 202412:11 pmRNSResults of General Meeting
8th Oct 20249:19 amRNSHolding(s) in Company
2nd Oct 202411:05 amRNSPosting of Annual Report and Notice of GM
1st Oct 20247:00 amRNSFinal Results
30th Sep 202410:48 amRNSResult of AGM
19th Sep 20244:14 pmRNSHolding(s) in Company
4th Sep 20241:36 pmRNSPosting of Notice of Annual General Meeting
2nd Sep 20247:00 amRNSGas Sale Agreement Signed with Sembcorp
22nd Aug 20249:02 amRNSBoard Restructure
26th Jul 20248:30 amRNSIssue of Salary Sacrifice Shares
24th Jun 20247:00 amRNSMako Binding Gas Sale Agreement Signed with PGN
13th Jun 20247:00 amRNSBlock 29/11 China update
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM
26th Sep 202212:01 pmRNSPosting of Annual Report and Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.